Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of IFITM2 mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of IFITM2 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of IFITM2 mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
IFITM2 mRNA results in decreased susceptibility to Arsenic | decreases response to substance | 17976673
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of IFITM2 mRNA | decreases expression | 15336504
|
D002104 |
Cadmium |
Cadmium results in increased expression of IFITM2 mRNA | increases expression | 17547211
|
D019256 |
Cadmium Chloride |
Cadmium Chloride results in increased expression of IFITM2 mRNA | increases expression | 17547211
|
C459604 |
candoxin |
candoxin results in decreased expression of IFITM2 mRNA | decreases expression | 16309724
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of IFITM2 mRNA | decreases expression | 20106945
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine results in increased expression of IFITM2 mRNA | increases expression | 17547211
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of IFITM2 mRNA | increases expression | 18035473
|
C010176 |
halofuginone |
halofuginone results in increased expression of IFITM2 mRNA | increases expression | 17180598
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of IFITM2 mRNA | affects cotreatment|increases expression | 17183730
|
C406082 |
monomethylarsonous acid |
[monomethylarsonous acid affects the acetylation of HIST3H3 protein] which affects the methylation of IFITM2 promoter | affects acetylation|affects methylation | 18448484
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of IFITM2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D012643 |
Selenium |
Selenium results in increased expression of IFITM2 mRNA | increases expression | 19244175
|
C017947 |
sodium arsenite |
[sodium arsenite affects the acetylation of HIST3H3 protein] which affects the methylation of IFITM2 promoter | affects acetylation|affects methylation | 18448484
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of IFITM2 mRNA | decreases expression | 12377979
|
C446685 |
systhane |
systhane results in increased expression of IFITM2 mRNA | increases expression | 16643972
|
C032910 |
triadimefon |
triadimefon results in increased expression of IFITM2 mRNA | increases expression | 16643972
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of IFITM2 mRNA | affects cotreatment|increases expression | 17183730
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of IFITM2 mRNA | increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.38 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.83 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.45 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.01 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
2.86 | 16033868 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
3.49 | 19555203 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.37 | 16434500 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.59 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
13.44 | 17306315 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
13.44 | 16712894 17306315 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.13 | 17688650 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.74 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.48 | 17497229 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.84 | 18414634 12569548 16835338 16251483 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
6.81 | 12928151 19371607 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
6.81 | 15687053 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 17507914 18396377 18985861 18177632 18316065 19232924 18558336 16609825 20603192 17157402 15238991 18940202 17688650 19460635 18775368 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.02 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.04 | 19483382 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.33 | 8888407 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.82 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
3.93 | 19555203 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.53 | 17687452 15504454 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
6.44 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
6.44 | 12619106 12907637 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
6.44 | 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
6.44 | 15276417 17306315 16507464 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
7.50 | 17687452 18922899 15504454 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
7.50 | 16033868 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.50 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
3.98 | 18640142 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.37 | 15738583 17938729 19152805 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.21 | 16973168 18022660 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.52 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
15.49 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
15.49 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
monomethylarsonous acid |
15.49 | 19716837 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
15.49 | 19524636 20056578 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.67 | 20734317 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.49 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.49 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
triadimefon |
3.68 | 16781842 |
MESH:D003092 |
Colitis |
|
Selenium |
3.67 | 17936198 |
MESH:D019465 |
Craniofacial Abnormalities |
|
triadimefon |
3.93 | 16875885 15834900 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.93 | 16575769 8888407 17688650 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
3.93 | 19769572 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.38 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
8.75 | 12153990 17906064 19164858 11461765 12392966 12958197 11743745 14725611 11529661 16109766 11739529 11287661 16485898 10915739 10663392 11421492 19370779 12705907 17562736 19420014 12594235 16227642 14550746 14986274 12540782 15968718 16393943 16081117 18713872 17522070 2444490 19085960 19923254 16781746 10774834 19416960 15619225 11834606 16177239 18071297 19739265 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
8.75 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
8.75 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
8.75 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.99 | 19426721 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.94 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.60 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.38 | 12083418 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.04 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.81 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.88 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.49 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.19 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.96 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
2.88 | 17016578 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
12.48 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
12.48 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
12.48 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.78 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.02 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.03 | 12168785 12639820 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.45 | 6392382 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.57 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.57 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.11 | 8708960 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
2.93 | 16080930 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.73 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
6.73 | 17162251 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.31 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
14.14 | 16221962 19772884 18467677 19176532 |
MESH:D006529 |
Hepatomegaly |
|
systhane |
14.14 | 17178689 17178688 |
MESH:D006529 |
Hepatomegaly |
|
triadimefon |
14.14 | 17178688 17178689 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.66 | 16490937 16863852 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.06 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
3.87 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.76 | 17688650 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.61 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.08 | 20558911 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.36 | 17050553 |
MESH:D006965 |
Hyperplasia |
|
halofuginone |
5.14 | 11874485 |
MESH:D006973 |
Hypertension |
|
Arsenic |
5.16 | 16076760 9931084 11953799 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.16 | 10903974 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.52 | 16612254 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.45 | 16093927 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.92 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
2.59 | 17296493 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
10.61 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
10.61 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.56 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
triadimefon |
4.86 | 15992940 15834900 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.34 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.88 | 12749816 16930632 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
23.06 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
23.06 | 16962696 16226777 16322080 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
23.06 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
23.06 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
23.06 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
23.06 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.78 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.64 | 12371664 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.13 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
3.48 | 17339181 |
MESH:D008103 |
Liver Cirrhosis |
|
halofuginone |
3.97 | 17180598 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
4.94 | 16544323 18364076 16270385 18095165 15842777 17348192 12918455 18672772 15339415 18237412 17640959 15492853 15733078 14709902 18371158 15864749 15366600 15086199 17196135 15763062 15298665 15138612 16603200 17881167 18567088 17432682 18637143 16042886 15383259 17036385 16570917 15942678 15723089 15067225 14726149 15099470 17198567 18210741 15591649 12925901 17724770 17719030 14568256 17465448 18629640 15479170 15798949 14659978 18239293 15081153 17534399 17666798 15504291 16009107 15161499 16627068 15571005 14643895 17201889 15793283 16169303 17203207 15577212 15369754 15744066 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
halofuginone |
4.94 | 18458672 14739098 11172339 12175628 16489207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.94 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
4.94 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.52 | 19784758 11587558 12969438 12587719 19460945 16610002 19014921 16611625 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
6.52 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
triadimefon |
6.52 | 19363144 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
9.35 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
9.35 | 17457977 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
17.47 | 9163691 18177683 2125692 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
17.47 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
17.47 | 3113478 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
17.47 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
17.47 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
triadimefon |
17.47 | 19028983 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
13.73 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
13.73 | 15603536 6150874 1848544 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
systhane |
13.73 | 17178689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
triadimefon |
13.73 | 17178689 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.20 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
7.20 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.16 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
6.47 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
6.47 | 17306315 19168569 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
6.47 | 16061637 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.47 | 17306315 19931552 16712894 17077188 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
6.47 | 11062179 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
2.69 | 15318939 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.02 | 19082730 16487513 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.46 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.75 | 15107826 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.68 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.11 | 18803445 18765137 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.40 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.92 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.09 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.10 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
3.89 | 15371236 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.86 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.76 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.76 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.56 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.34 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.19 | 19348381 18481113 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
11.80 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.80 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
11.80 | 8888407 16359493 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.78 | 18514411 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.27 | 17056641 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.79 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
4.92 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.92 | 15276417 17306315 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.30 | 16870215 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.07 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
12.72 | 16905509 6392382 15371236 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
12.72 | 15687053 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.78 | 15087411 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.13 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
3.72 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.15 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
2.15 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.15 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.15 | 15084515 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
3.90 | 21343184 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.44 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.19 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.33 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.07 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.05 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.66 | 11044598 17978042 3137016 11738929 14763951 16876388 1511512 15475178 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
11.20 | 19834688 17453740 16702368 6392382 17050553 17548696 17938729 15952646 16759981 18709164 16353154 |
MESH:D012871 |
Skin Diseases |
|
halofuginone |
11.20 | 11874485 |
MESH:D012871 |
Skin Diseases |
|
monomethylarsonous acid |
11.20 | 17431481 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
11.20 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
9.27 | 17029826 15504454 17976673 16251483 17050553 19538983 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.27 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
9.27 | 8532709 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
9.26 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
9.26 | 19490988 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
5.16 | 12587719 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.44 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
2.45 | 16033868 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.43 | 16517955 |
MESH:D013964 |
Thyroid Neoplasms |
|
triadimefon |
4.00 | 17178689 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.13 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.41 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
8.29 | 19322015 17306315 11144890 19429237 17976673 18640142 15987713 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
monomethylarsonous acid |
8.29 | 20375083 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.29 | 16712894 11723127 17306315 16452187 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.53 | 8888407 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.87 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.67 | 11813266 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.88 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
11.48 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
11.48 | 17056641 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.34 | 17120751 |